SSA
MIRA icon

Schonfeld Strategic Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,900
Closed -$54.5K – 2246
2024
Q3 		$54.5K Buy
+41,900
New +$66.8K ﹤0.01% 1886

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Schonfeld Strategic Advisors's MIRA Position: Q4 2024 in Review

Schonfeld Strategic Advisors sold out of MIRA Pharmaceuticals (MIRA) in Q4 2024, closing a stake of 41,900 shares — an estimated $54.5K sold.

Schonfeld Strategic Advisors first reported a position in MIRA in Q3 2024 and held it in 1 quarter. The position peaked at $54.5K in Q3 2024. 24 funds tracked by Wall St. Rank hold MIRA as of Q4 2024.

  • Schonfeld Strategic Advisors reported no remaining MIRA Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 41,900 MIRA Pharmaceuticals shares in Q4 2024, an estimated $54.5K.
  • Schonfeld Strategic Advisors first reported a position in MIRA Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's MIRA Pharmaceuticals position peaked at $54.5K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.